Read more
1:53 PM · 17 April 2023

Top stock reports to watch this week (17.04.2023)

Big US banks launched Q1 2023 Wall Street earnings season last week. First reports from major banks turned out to be mostly better-than-expected but accompanying commentary warned that the economy could struggle going forward. Earnings stream gets more diverse this week and traders will be offered first reports from some big-name US tech companies.

A total of 6 Dow Jones members will report earnings this week - Goldman Sachs, Johnson & Johnson, IBM, Travelers, American Express and Procter & Gamble. Apart from that, Netflix is set to release its Q1 earnings report on Tuesday after market close while Tesla will release its financials on Wednesday, also after close of the market. Full calendar of top US earnings can be found in the table below.

Top US stock reports to watch this week. Source: Bloomberg, XTB

7 May 2026, 9:46 PM

Daily Summary: A shift in sentiment at the end of the day 💥⬇️

7 May 2026, 5:50 PM

Stock of the Week AMD: From second choice to core pillar of the AI infrastructure

7 May 2026, 5:46 PM

US OPEN: Wall Street opens higher 🔼 Datadog and ARM in the spotlight 💥

7 May 2026, 3:51 PM

Rheinmetall earninigs: Weak sales overshadow strong prospects

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.